Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Abeona Therapeutics (Nasdaq: ABEO) announced participation in two investor conferences in June 2026.

Management will join a fireside chat at the 2026 Jefferies Global Healthcare Conference at 3:10 PM ET on Thursday, June 4, 2026, and hold investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 on Monday, June 8, 2026. A live webcast and replay of the Jefferies fireside chat will be available in the Investors "Events" section of Abeona's website.

News Market Reaction – ABEO

+0.92%

+0.92% Session close to close

In the May 26 session, ABEO gained 0.92%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CLEVELAND, May 26, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in June 2026:

• 2026 Jefferies Global Healthcare Conference: Fireside chat at 3:10 PM ET on Thursday, June 4, 2026 and investor meetings.
  
• Goldman Sachs 47^th Annual Global Healthcare Conference 2026: Investor meetings on Monday, June 8, 2026.
  

A live webcast of the fireside chat can be accessed on the Investors section of the Abeona website under "Events" at https://investors.abeonatherapeutics.com/events, where a replay of the event will also be available for a limited time.

About Abeona Therapeutics

Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s ZEVASKYN^® (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. The Company’s development portfolio features ABO-701 (PSMA-SIR-T™), a potentially first-in-class engineered T-cell therapy targeting PSMA, engineered to overcome the core failures of cell therapies in solid tumors. For more information, visit www.abeonatherapeutics.com.

ZEVASKYN^®, Abeona Assist™, Abeona Therapeutics^®, and their related logos are trademarks of Abeona Therapeutics Inc.

Contacts:

Investor and Media
Greg Gin
VP, Investor Relations and Corporate Communications
Abeona Therapeutics
ir@abeonatherapeutics.com

Investor
Lee M. Stern
Meru Advisors
lstern@meruadvisors.com

FAQ

When will Abeona Therapeutics (NASDAQ: ABEO) present at the 2026 Jefferies Global Healthcare Conference?

Abeona Therapeutics will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, 2026, at 3:10 PM ET. According to Abeona, management will also host related investor meetings.

How can investors watch Abeona Therapeutics' Jefferies 2026 fireside chat webcast?

Investors can watch the Jefferies 2026 fireside chat via live webcast on Abeona’s website in the Investors section under “Events.” According to Abeona, a replay will also be available online for a limited time.

What is Abeona Therapeutics (ABEO) doing at the Goldman Sachs 47th Annual Global Healthcare Conference 2026?

Abeona Therapeutics plans to hold investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 on Monday, June 8, 2026. According to Abeona, these meetings are part of its June 2026 investor conference participation.

Where can shareholders find details about Abeona Therapeutics (ABEO) June 2026 investor events?

Shareholders can find details about Abeona’s June 2026 investor events in the Investors “Events” section of its website. According to Abeona, this page will host the Jefferies webcast and its replay for a limited period.